ArticleCancer imaging : the official publication of the International Cancer Imaging Society2023

Comparing the effectiveness and safety of Sorafenib plus TACE with Apatinib plus TACE for treating patients with unresectable hepatocellular carcinoma: a multicentre propensity score matching study.

Liang Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.